graphene-info.com /3 weeks ago

Hawkeye Bio’s graphene-biosensor lung cancer blood test LEAP becomes commercially available

Hawkeye Bio and HealthQuest Esoterics, a clinical reference laboratory in Irvine, California, have announced the commercial availability of LEAP (Lung Enzyme Activity Profile), a p...

Read source
rna-seqblog.com /1 month ago

Urine test may improve bladder cancer diagnosis and guide treatment decisions

RNA sequencing of urine cell-free RNA can detect bladder cancer, monitor residual disease and help predict whether patients may respond better to immunotherapy or chemotherapy...

Read source
fiercehealthcare.com /1 month ago

How MRD is powering the next wave of precision oncology

The Oncodetect® molecular residual disease test is giving clinicians insights that can reshape cancer treatment and monitoring.

Read source
journals.plos.org /1 month ago

Genome-Wide DNA methylation profiling of tissue-plasma pairs identifies Novel cfDNA biomarkers for the diagnosis of gast...

by Hailing Ou, Jinli Miao, Fusheng Ling, Jie Gao, Tingan Wang, Zhihua Ye, Chunbo Zhang, Mingwei Huang, Yuzhou Qin Screening for gastric cancer (GC) is critical for improving patie...

Read source
nanowerk.com /1 month ago

Laser-powered method detects elusive cancer biomarkers in minutes

A light-induced detection method rapidly measures tiny amounts of the colorectal cancer biomarker CEACAM-5 in blood plasma, revealing that it forms nanoscale aggregates.

Read source
elle.com /1 month ago

Could a Breast Cancer Blood Test Be the Future?

What if you could detect metastatic breast cancer with just a blood test?

Read source
mindbodygreen.com /1 month ago

A New Blood Test Found A Surprising Signal In Early-Stage Cancer

Scientists are exploring a less invasive way to find cancer sooner.

Read source
biopharmadive.com /1 month ago

Grail multicancer detection test wins FDA advisers’ backing

Panel members said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings, however.

Read source
wlky.com /1 month ago

FDA panel endorses first-of-a-kind cancer blood test

Federal health advisers endorsed an experimental blood test designed to spot signs of various cancers in apparently healthy people. Here's how the technology works.

Read source
newswire.com /3 weeks ago

Glioblastoma Foundation's Genomic Testing & Research Laboratory Now Accepting Patient Samples for Genomic Testing

The Foundation's CLIA-certified laboratory combines DNA methylation profiling, MGMT status, copy-number variation analysis and glioblastoma subtype characterization in a single ass...

Read source
kmbc.com /1 month ago

FDA panel endorses first-of-a-kind cancer blood test

Federal health advisers endorsed an experimental blood test designed to spot signs of various cancers in apparently healthy people. Here's how the technology works.

Read source
healio.com /1 month ago

FDA panel supports multicancer early detection test

An FDA advisory panel expressed support for a blood test designed to detect early signs of multiple cancers, including some for which no screening alternative exists.Members of the...

Read source
reviewjournal.com /1 month ago

FDA panel endorses first-of-its-kind cancer blood test

Grail Inc.’s Galleri test doesn’t diagnose cancer but instead, with a single blood draw, looks for a signal that someone might have one of a long list of tumors.

Read source
scmp.com /1 month ago

US regulators back multi-cancer blood test – but Hong Kong doctors remain cautious

Efforts to detect multiple cancers through a single blood draw are gathering momentum after US regulators endorsed the technology for the first time, although experts say wider ado...

Read source
scientificamerican.com /1 month ago

Blood test for multiple cancers clears crucial hurdle on track to FDA approval

If approved, the test could help catch cancers early—but more research is still needed, experts say

Read source
pharmexec.com /2 weeks ago

<![CDATA[How Testing Tumors After Recurrence be Improved]]>

Read source
bioengineer.org /3 weeks ago

Ascites Cell Blocks Enable Ovarian Cancer Diagnosis and Molecular Profiling

A study of 58 patients found that ovarian cancer ascites-derived cell blocks supported immunohistochemical diagnosis and detected homologous recombination repair gene mutations in...

Read source
scmp.com /4 weeks ago

‘Really terrified’: how a blood test could spare cancer patients an agonising wait

In the second of a four-part Health Matters wellness series on frontier medicine in Hong Kong, Fiona Sun looks into how a new PCR system can detect cancer, infections and birth def...

Read source
newswire.com /2 days ago

DataMEDS AI Agrees to Acquire TBIA Cancer AI Blood Test Platform From Todos Medical Estate for Subsidiary Helomics, Inc.

CLIA-Certified Cancer Diagnostics Laboratory Will Acquire Spectroscopy Platform to Support Machine Learning Expansion into Additional Cancer TypesCE Marks previously held in Europe...

Read source
bioengineer.org /1 month ago

Tiny Brain Vesicles in Blood Could Transform Diagnosis of Neurological Disease

A new review details how extracellular vesicles carrying brain-derived proteins and RNAs could enable minimally invasive diagnosis of Alzheimer's, Parkinson's, stroke, glioma and o...

Read source
nbcdfw.com /1 month ago

FDA panel endorses first-of-a-kind cancer blood test

Federal health advisers on Wednesday endorsed a blood test designed to spot signs of various cancers in apparently healthy people while warning that it’s far from clear how well th...

Read source
bioengineer.org /1 week ago

Circulating Serum RNA Transcripts Differ Between Latent and Active Tuberculosis

Host-derived serum RNA transcripts CXCL10, L6, and CVIL demonstrate significant abundance differences between latent and active tuberculosis infections in a real-time qPCR evaluati...

Read source
mindbodygreen.com /1 month ago

Blood Test That Screens For Multiple Cancers Shows Promise In 36K Person Trial

Fair warning: this does NOT replace your colonoscopy (yet).

Read source
mindbodygreen.com /1 month ago

Blood Test That Screens For Multiple Cancers Shows Promise In 36K Person Trial

Fair warning: this does NOT replace your colonoscopy (yet).

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.